| 1 |
Gao Y, Rosen JM, Zhang XH. The tumor-immune ecosystem in shaping metastasis. Am J Physiol Cell Physiol 2023;324:C707-17. [PMID: 36717100 DOI: 10.1152/ajpcell.00132.2022] [Reference Citation Analysis]
|
| 2 |
She X, Shen S, Chen G, Gao Y, Ma J, Gao Y, Liu Y, Gao G, Zhao Y, Wang C, Jiang C, Wang P, Qin H, Gao H. Immune surveillance of brain metastatic cancer cells is mediated by IFITM1. EMBO J 2023;:e111112. [PMID: 36799040 DOI: 10.15252/embj.2022111112] [Reference Citation Analysis]
|
| 3 |
Correia AL. Locally sourced: site-specific immune barriers to metastasis. Nat Rev Immunol 2023;:1-17. [PMID: 36750616 DOI: 10.1038/s41577-023-00836-2] [Reference Citation Analysis]
|
| 4 |
Wei-Wei Chen, Timothy Shun Man Chu, LiangLiang Xu, Cai-Ning Zhao, Wai-Sang Poon, Gilberto Ka-Kit Leung, Feng-Ming (Spring) Kong. Immune related biomarkers for cancer metastasis to the brain. Exp Hematol Oncol 2022;11:105. [PMID: 36527157 DOI: 10.1186/s40164-022-00349-z] [Reference Citation Analysis]
|
| 5 |
Caffarel MM, Braza MS. Microglia and metastases to the central nervous system: victim, ravager, or something else? J Exp Clin Cancer Res 2022;41:327. [PMID: 36411434 DOI: 10.1186/s13046-022-02535-7] [Reference Citation Analysis]
|
| 6 |
Berg TJ, Pietras A. Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells. Semin Cancer Biol 2022;86:846-56. [PMID: 35143991 DOI: 10.1016/j.semcancer.2022.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 7 |
Blazquez R, Chuang HN, Wenske B, Trigueros L, Wlochowitz D, Liguori R, Ferrazzi F, Regen T, Proescholdt MA, Rohde V, Riemenschneider MJ, Stadelmann C, Bleckmann A, Beißbarth T, van Rossum D, Hanisch UK, Pukrop T. Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain. Oncogene 2022. [PMID: 36224342 DOI: 10.1038/s41388-022-02496-3] [Reference Citation Analysis]
|
| 8 |
Zhang Q, Abdo R, Iosef C, Kaneko T, Cecchini M, Han VK, Li SS. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Nat Commun 2022;13:5983. [PMID: 36216799 DOI: 10.1038/s41467-022-33365-y] [Reference Citation Analysis]
|
| 9 |
Campbell BK, Gao Z, Corcoran NM, Stylli SS, Hovens CM. Molecular Mechanisms Driving the Formation of Brain Metastases. Cancers (Basel) 2022;14:4963. [PMID: 36230886 DOI: 10.3390/cancers14194963] [Reference Citation Analysis]
|
| 10 |
Mirzaei R, Yong VW. Microglia-T cell conversations in brain cancer progression. Trends Mol Med 2022:S1471-4914(22)00211-8. [PMID: 36075812 DOI: 10.1016/j.molmed.2022.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Wang Y, Chen R, Wa Y, Ding S, Yang Y, Liao J, Tong L, Xiao G. Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer. Front Immunol 2022;13:829451. [PMID: 35251014 DOI: 10.3389/fimmu.2022.829451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Procissi D, Jannetti SA, Zannikou M, Zhou Z, Mcdougald D, Kanojia D, Vaidyanathan G, Zalutsky MR, Balyasnikova IV. Low Level Whole-Brain Radiation Enhances Theranostic Potential Of Single Domain Antibody Fragments For HER2-Positive Brain Metastases.. [DOI: 10.1101/2022.04.19.488555] [Reference Citation Analysis]
|
| 13 |
Economopoulos V, Pannell M, Johanssen VA, Scott H, Andreou KE, Larkin JR, Sibson NR. Inhibition of Anti-Inflammatory Macrophage Phenotype Reduces Tumour Growth in Mouse Models of Brain Metastasis. Front Oncol 2022;12:850656. [PMID: 35359423 DOI: 10.3389/fonc.2022.850656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Procissi D, Jannetti SA, Zannikou M, Zhou Z, Mcdougald D, Kanojia D, Zhang H, Burdett K, Vaidyanathan G, Zalutsky MR, Balyasnikova IV. Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases. Neuro-Oncology Advances 2022;4. [DOI: 10.1093/noajnl/vdac135] [Reference Citation Analysis]
|
| 15 |
Andersen BM, Faust Akl C, Wheeler MA, Chiocca EA, Reardon DA, Quintana FJ. Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat Rev Cancer 2021;21:786-802. [PMID: 34584243 DOI: 10.1038/s41568-021-00397-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 16 |
Klemm F, Möckl A, Salamero-Boix A, Alekseeva T, Schäffer A, Schulz M, Niesel K, Maas RR, Groth M, Elie BT, Bowman RL, Hegi ME, Daniel RT, Zeiner PS, Zinke J, Harter PN, Plate KH, Joyce JA, Sevenich L. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. Nat Cancer 2021;2:1086-101. [PMID: 35121879 DOI: 10.1038/s43018-021-00254-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 17 |
Zhang W, Karschnia P, von Mücke-Heim IA, Mulazzani M, Zhou X, Blobner J, Mueller N, Teske N, Dede S, Xu T, Thon N, Ishikawa-Ankerhold H, Straube A, Tonn JC, von Baumgarten L. In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer. Neoplasia 2021;23:1089-100. [PMID: 34587566 DOI: 10.1016/j.neo.2021.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Schulz M, Sevenich L. TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man. Front Immunol 2021;12:716504. [PMID: 34539650 DOI: 10.3389/fimmu.2021.716504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 19 |
Klemm F, Schäffer A, Salamero-boix A, Alekseeva T, Schulz M, Niesel K, Maas RR, Groth M, Elie BT, Bowman RL, Hegi ME, Daniel RT, Zeiner PS, Zinke J, Harter PN, Plate KH, Joyce JA, Sevenich L. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis.. [DOI: 10.1101/2021.06.07.447034] [Reference Citation Analysis]
|
| 20 |
Tsukamoto H, Komohara Y, Oshiumi H. The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets. Hum Cell 2021;34:1031-9. [PMID: 33905102 DOI: 10.1007/s13577-021-00514-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Uriarte Huarte O, Richart L, Mittelbronn M, Michelucci A. Microglia in Health and Disease: The Strength to Be Diverse and Reactive. Front Cell Neurosci 2021;15:660523. [PMID: 33867943 DOI: 10.3389/fncel.2021.660523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 22 |
Niesel K, Schulz M, Anthes J, Alekseeva T, Macas J, Salamero-Boix A, Möckl A, Oberwahrenbrock T, Lolies M, Stein S, Plate KH, Reiss Y, Rödel F, Sevenich L. The immune suppressive microenvironment affects efficacy of radio-immunotherapy in brain metastasis. EMBO Mol Med 2021;13:e13412. [PMID: 33755340 DOI: 10.15252/emmm.202013412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 23 |
Masmudi-Martín M, Zhu L, Sanchez-Navarro M, Priego N, Casanova-Acebes M, Ruiz-Rodado V, Giralt E, Valiente M. Brain metastasis models: What should we aim to achieve better treatments? Adv Drug Deliv Rev 2021;169:79-99. [PMID: 33321154 DOI: 10.1016/j.addr.2020.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
